温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.prnewswire.com/news-releases/health-latest-news/clinical-trials-medical-discoveries-list
点击访问原文链接

All Clinical Trials & Medical Discoveries News and Press Releases from PR Newswire

进入原网站 导航首页
Accessibility StatementResourcesInvestor RelationsJournalistsAgenciesClient LoginSend a ReleaseNewsProductsContactBrowse News ReleasesAll News ReleasesAll Public CompanyEnglish-onlyNews Releases OverviewMultimedia GalleryAll MultimediaAll PhotosAll VideosMultimedia Gallery OverviewTrending TopicsAll Trending TopicsAuto & TransportationAll Automotive & TransportationAerospace, DefenseAir FreightAirlines & AviationAutomotiveMaritime & ShipbuildingRailroads and Intermodal TransportationSupply Chain/LogisticsTransportation, Trucking & RailroadTravelTrucking and Road TransportationAuto & Transportation OverviewView All Auto & TransportationBusiness TechnologyAll Business TechnologyBlockchainBroadcast TechComputer & ElectronicsComputer HardwareComputer SoftwareData AnalyticsElectronic CommerceElectronic ComponentsElectronic Design AutomationFinancial TechnologyHigh Tech SecurityInternet TechnologyNanotechnologyNetworksPeripheralsSemiconductorsBusiness Technology OverviewView All Business TechnologyEntertain­ment & MediaAll Entertain­ment & MediaAdvertisingArtBooksEntertainmentFilm and Motion PictureMagazinesMusicPublishing & Information ServicesRadio & PodcastTelevisionEntertain­ment & Media OverviewView All Entertain­ment & MediaFinancial Services & InvestingAll Financial Services & InvestingAccounting News & IssuesAcquisitions, Mergers and TakeoversBanking & Financial ServicesBankruptcyBond & Stock RatingsConference Call AnnouncementsContractsCryptocurrencyDividendsEarningsEarnings Forecasts & ProjectionsFinancing AgreementsInsuranceInvestments OpinionsJoint VenturesMutual FundsPrivate PlacementReal EstateRestructuring & RecapitalizationSales ReportsShareholder ActivismShareholder MeetingsStock OfferingStock SplitVenture CapitalFinancial Services & Investing OverviewView All Financial Services & InvestingGeneral BusinessAll General BusinessAwardsCommercial Real EstateCorporate ExpansionEarningsEnvironmental, Social and Governance (ESG)Human Resource & Workforce ManagementLicensingNew Products & ServicesObituariesOutsourcing BusinessesOverseas Real Estate (non-US)Personnel AnnouncementsReal Estate TransactionsResidential Real EstateSmall Business ServicesSocially Responsible InvestingSurveys, Polls and ResearchTrade Show NewsGeneral Business OverviewView All General BusinessConsumer TechnologyAll Consumer TechnologyArtificial IntelligenceBlockchainCloud Computing/Internet of ThingsComputer ElectronicsComputer HardwareComputer SoftwareConsumer ElectronicsCryptocurrencyData AnalyticsElectronic CommerceElectronic GamingFinancial TechnologyMobile EntertainmentMultimedia & InternetPeripheralsSocial MediaSTEM (Science, Tech, Engineering, Math)Supply Chain/LogisticsWireless CommunicationsConsumer Technology OverviewView All Consumer TechnologyEnergy & Natural ResourcesAll EnergyAlternative EnergiesChemicalElectrical UtilitiesGasGeneral ManufacturingMiningMining & MetalsOil & EnergyOil and Gas DiscoveriesUtilitiesWater UtilitiesEnergy & Natural Resources OverviewView All Energy & Natural ResourcesEnviron­mentAll Environ­mentConservation & RecyclingEnvironmental IssuesEnvironmental PolicyEnvironmental Products & ServicesGreen TechnologyNatural DisastersEnviron­ment OverviewView All Environ­mentHeavy Industry & ManufacturingAll Heavy Industry & ManufacturingAerospace & DefenseAgricultureChemicalConstruction & BuildingGeneral ManufacturingHVAC (Heating, Ventilation and Air-Conditioning)MachineryMachine Tools, Metalworking and MetallurgyMiningMining & MetalsPaper, Forest Products & ContainersPrecious MetalsTextilesTobaccoHeavy Industry & Manufacturing OverviewView All Heavy Industry & ManufacturingTelecomm­unicationsAll Telecomm­unicationsCarriers and ServicesMobile EntertainmentNetworksPeripheralsTelecommunications EquipmentTelecommunications IndustryVoIP (Voice over Internet Protocol)Wireless CommunicationsTelecomm­unications OverviewView All Telecomm­unicationsConsumer Products & RetailAll Consumer Products & RetailAnimals & PetsBeers, Wines and SpiritsBeveragesBridal ServicesCannabisCosmetics and Personal CareFashionFood & BeveragesFurniture and FurnishingsHome ImprovementHousehold, Consumer & CosmeticsHousehold ProductsJewelryNon-Alcoholic BeveragesOffice ProductsOrganic FoodProduct RecallsRestaurantsRetailSupermarketsToysConsumer Products & Retail OverviewView All Consumer Products & RetailEntertain­ment & MediaAll Entertain­ment & MediaAdvertisingArtBooksEntertainmentFilm and Motion PictureMagazinesMusicPublishing & Information ServicesRadio & PodcastTelevisionEntertain­ment & Media OverviewView All Entertain­ment & MediaHealthAll HealthBiometricsBiotechnologyClinical Trials & Medical DiscoveriesDentistryFDA ApprovalFitness/WellnessHealth Care & HospitalsHealth InsuranceInfection ControlInternational Medical ApprovalMedical EquipmentMedical PharmaceuticalsMental HealthPharmaceuticalsSupplementary MedicineHealth OverviewView All HealthSportsAll SportsGeneral SportsOutdoors, Camping & HikingSporting EventsSports Equipment & AccessoriesSports OverviewView All SportsTravelAll TravelAmusement Parks and Tourist AttractionsGambling & CasinosHotels and ResortsLeisure & TourismOutdoors, Camping & HikingPassenger AviationTravel IndustryTravel OverviewView All TravelPolicy & Public InterestAll Policy & Public InterestAdvocacy Group OpinionAnimal WelfareCongressional & Presidential CampaignsCorporate Social ResponsibilityDomestic PolicyEconomic News, Trends, AnalysisEducationEnvironmentalEuropean GovernmentFDA ApprovalFederal and State LegislationFederal Executive Branch & AgencyForeign Policy & International AffairsHomeland SecurityLabor & UnionLegal IssuesNatural DisastersNot For ProfitPatent LawPublic SafetyTrade PolicyU.S. State PolicyPolicy & Public Interest OverviewView All Policy & Public InterestPeople & CultureAll People & CultureAboriginal, First Nations & Native AmericanAfrican AmericanAsian AmericanChildrenDiversity, Equity & InclusionHispanicLesbian, Gay & BisexualMen's InterestPeople with DisabilitiesReligionSenior CitizensVeteransWomenPeople & Culture OverviewView All People & CultureArabicespañolportuguêsČeskoDanmarkDeutschlandEspañaFranceItaliaNederlandNorgePolskaPortugalРоссияSlovenskoSuomiSverigeExplore Our PlatformPlan CampaignsCreate with AIDistribute Press ReleasesAmplify ContentAll ProductsGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesSend a ReleaseALL CONTACT INFOContact UsSend a ReleaseClient LoginResourcesBlogJournalistsRSSBrowse All NewsMultimedia GalleryTrending TopicsAuto & TransportationBusiness TechnologyEntertain­ment & MediaFinancial Services & InvestingGeneral BusinessConsumer TechnologyEnergy & Natural ResourcesEnviron­mentHeavy Industry & ManufacturingTelecomm­unicationsConsumer Products & RetailEntertain­ment & MediaHealthSportsTravelPeople & CultureSend a ReleaseClient LoginResourcesBlogJournalistsRSSExplore Our PlatformPlan CampaignsCreate with AIDistribute Press ReleasesAmplify ContentAll ProductsSend a ReleaseClient LoginResourcesBlogJournalistsRSSGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesSend a ReleaseClient LoginResourcesBlogJournalistsRSSApr 03, 2026, 10:44 ET Fast-Acting Covalent Protein Drugs From a New High-Throughput Platform A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput...Apr 03, 2026, 08:00 ET New Clinical Trial Published on Specialty Enzymes & Probiotics' Bactase Pet PB™ Specialty Enzymes & Probiotics announces the publication of a clinical study demonstrating the oral health benefits of Bactase Pet PB™, a proprietary ...Apr 03, 2026, 07:32 ET Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators,...Apr 02, 2026, 14:30 ET The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy The University of Colorado Anschutz Gates Institute has received Investigational New Drug clearance from the U.S. Food and Drug Administration,...Apr 02, 2026, 12:03 ET La FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o agua Eli Lilly and Company (NYSE: LLY) ha anunciado hoy que la Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) aprobó Foundayo™ ...Apr 02, 2026, 10:17 ET Clinical AI Announces the Launch of MAIA™ Prescreening on Google Cloud Marketplace Clinical AI, a healthcare artificial intelligence company focused on modernizing clinical trial operations, today announced that MAIA™ Prescreening...Apr 02, 2026, 09:50 ET Florida Cancer Specialists & Research Institute Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic Cancers Results of a Phase 1 clinical study conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) have provided...Apr 02, 2026, 08:45 ET Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease Panoramic Science, the clinical research division of Panoramic Health, and West Coast Kidney Institute today announced the launch of the Concord...Apr 02, 2026, 08:15 ET CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials CellCarta, a global provider of precision medicine laboratory services for drug development, and Pillar Biosciences, a leader in NGS-based oncology...Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association's annual conference in San Diego showing that Wegovy®...Apr 02, 2026, 08:00 ET Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association's annual conference in San Diego showing that Wegovy®...Apr 02, 2026, 07:33 ET NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS The National University Health System (NUHS) today showcased how advances in genomics, data science and digital health are accelerating Singapore's...Apr 02, 2026, 07:30 ET Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...Apr 02, 2026, 07:30 ET PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects...Apr 02, 2026, 07:00 ET Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase...Apr 02, 2026, 06:00 ET AvenCell Therapeutics Announces First Patient Dosed in Phase I QUADvance Study with AVC-203, a Novel Allogeneic CD19/CD20 Dual-Targeting CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-Cell Malignancies AvenCell Therapeutics, Inc., a leading clinical-stage cell therapy company focused on advancing both switchable and allogeneic CAR-T cell therapies,...Apr 02, 2026, 00:04 ET Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company advancing innovative small-molecule therapies in aesthetic...Apr 01, 2026, 11:30 ET FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with...Apr 01, 2026, 10:19 ET Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis Vascarta Inc. today announced the publication of results from a randomized, double-blind, placebo-controlled clinical trial evaluating VAS-101, the...Apr 01, 2026, 09:00 ET Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation bispecific antibodies for...Apr 01, 2026, 09:00 ET From Commercialization to Global Leadership: Innogen (2591.HK) Unlocks the Strategic Value of Its Ultra-Long-Acting GLP-1 Receptor Agonist The release of Innogen's inaugural annual report following its Hong Kong listing serves not merely as a financial disclosure, but as a strategic...Apr 01, 2026, 08:54 ET New Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really? A new study has reported the effectiveness of raising glutathione levels in the blood through oral supplementation of liposomal glutathione. However, ...Apr 01, 2026, 08:50 ET Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today...Apr 01, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for April 2026 Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries....GET STARTEDPR Newswire for JournalistsSubmit a free ProfNet requestLEARN MOREGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesFor MarketersFor Public RelationsFor IR & ComplianceFor AgencyAll ProductsAbout PR NewswireAbout CisionBecome a Publishing PartnerBecome a Channel PartnerCareersAccessibility StatementAPACAPAC - Simplified ChineseAPAC - Traditional ChineseBrazilCanadaCzechDenmarkFinlandFranceGermanyIndiaIndonesiaIsraelItalyJapanKoreaMexicoMiddle EastMiddle East - ArabicNetherlandsNorwayPolandPortugalRussiaSlovakiaSpainSwedenUnited KingdomVietnamAll New ReleasesPlatform LoginProfNetData PrivacyDo not sell or share my personal information[email protected]Contact PR NewswireProductsAboutAll News ReleasesPlatform LoginProfNetTerms of UsePrivacy PolicyInformation Security PolicySite MapRSSCookiesCision

智能索引记录